chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cold; Initial information received on 16-Nov-2020 regarding an unsolicited valid non-serious social media case received from digital media via a consumer.  This case involves an unknown age patient who had cold (Nasopharyngitis ), while the patient received INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiration date not reported via unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced cold (Nasopharyngitis), unknown latency following the administration of INFLUENZA VACCINE.  No relevant laboratory test was reported.  Final diagnosis was Nasopharyngitis.  It was not reported if the patient received a corrective treatment.  The outcome was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
Patient received vaccine and went to go sit down. He asked for water and said he didn't feel well. He then slumped in his chair and started convulsing in his chair. His eyes rolled back and he was delirious when he came to and didn't know where he was. EMS was called.
RASH STARTED 12/04/09, SEEN IN ER ON 12/05/09 AS RASH WORSENED. SOLUMEDROL GIVEN. BETTER UNTIL 12/06/09 PM WORSE AGAIN. SEEN IN OFFICE 12/07/09, URTICARIA/VASCULITIS PLACED ON ORAPRED & ZYRTEC.
Severe R shoulder/arm pain since injection.  Upon receiveing the injection I experienced severe pain in my R shoulder joint, but the nurse told me that was normal.  Over the following hours/days/weeks the pain began to radiate up my neck, down my arm and into my scapula and lat areas.  My range of motion (ROM) had become severely limited and I began to experience neuropathies in my right arm and hand.  I tried all OTC pain relievers which had absolutely no effect.  On April 6th, I was in so much pain that I went to an urgent care clinic.  They provided me with prednisone, soma and celebrex (upon completion of steroid).  In addition, I started myself on gabapentin which was provided in the past.  I have one more day of celebrex remaining.   While my symptoms are not nearly as bad as they were, they have not resolved.  I continue to have pain in/around my R shoulder, neuropathy in my R arm and limited ROM/weakness cross-body and above 90 degrees.
COVID vaccination booster in late December.  Now with cardiomyopathy and worsening of congestive heart failure over the last 2 months since the booster.  EF has dropped to 30% from normal last year.
Rash onset 48 hours after vaccine. Moderate, pruritic, maculopapular, starting on hands, bilateral, gradually spread up both arms, then anterior trunk, then shins over course of many days, then fading in reverse fashion, now 2 weeks post vaccine with mild lingering on arms
Left thigh red and swollen on injection site, warm to touch. Seen by Dr. today at 10:00 am.
Specialist transferred physician who is requesting guidance on use of MMRII after an unspecified patient experienced a seizure that resulted in intubation. She states that earlier in the day the patient had received MMRII, VARIVAX and an unspecified; This spontaneous report was received from a physician and refers to a male patient of an unknown age. The patient's medical history was not reported. Concomitant therapies were not reported. On 21-SEP-2022, the patient was vaccinated with non-merck hepatitis A vaccine, with varicella virus vaccine live (oka/merck) (VARIVAX) and with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (strength, lot #, expiry date, and route of administration were not provided for all) all for prophylaxis. On the same day, he experienced seizure, that resulted in intubation. He sought medical attention. The outcome of the event was unknown. Relatedness between the event and suspect vaccines was not reported.  Upon internal review, the event of seizure was considered to be medically significant.
Day one:  Fatigue Day two:  Fatigue and mouth sores Day three:  Fatigue, itching at injection site, hives on both arms and on the neck, swelling of throat and itching in right ear. Day four:  Same as day three Day five:  Hives  almost gone (treated with topical medication), swelling of throat and itching in right ear. Sores in mouth starting to heal.  Day six to current: Swelling of throat and itching in right ear.
This solicited report as received from the patient's mother, as part of a marketing research program conducted by C Space, refers to a male patient of unknown age. Medical history and concurrent conditions were not reported. On an unknown date the patient was vaccinated with a dose of GARDASIL. Dose, route, lot number and expiration date were not provided. No other suspect or concomitant therapies were reported. On an unknown date at the Doctor's office, the patient's mother stated "My son said the shot was painful" (injection site pain). The outcome of the event was unknown. The causality between the event and the therapy with GARDASIL was unknown. Additional information is not expected because there is no consent to contact the Physician.
Information has been received from a physician concerning a female who was vaccinated with a dose of GARDASIL vaccine (yeast) (lot number, injection site and route not reported). A couple days after vaccination the patient fainted. Unspecified medical attention was sought. Additional information has been requested.
My mother, the patient, received the shot at 3:00 pm on a Wednesday. By 3:00 am Thursday morning, my mother became very weak and was unable to walk to the bathroom. She needed to be carried. The next morning she was very weak and needed to be dressed. She was also very subdued and "loopy". She ate breakfast and hearty bean soup for lunch, but by 4:00 pm Thursday she became nauseous and was running a low fever around 99. We gave her a NyQuil dose which she quickly vomited. From there she continued to vomit and her temperature went up. When she needed to use the restroom, I escorted her, but by the time we reached that area she could not follow instructions to sit down and was holding onto the door jamb. She had soiled herself while standing there.  Eventually I was able to get her to sit down and was able to clean her up and change her clothes. But she could not follow instructions to stand up. With a second caregiver, we were able to get her to stand up, but within three steps of the toilet her knees buckled and she was unable to stand. We sat her in a walker with a seat and rechecked her temperature. It had gone up to 103. At this time, we considered calling 911, but instead we put a cool cloth on the back of her neck and monitored her (with three people all standing round). After a while we were able to move her back to the family room where she insisted upon sitting on the couch. She was able to stand up from the walker and move a few steps to the couch. By 10 pm she was starting to drift off to sleep sitting up and her temperature was back down around 99. When we were putting her to bed, she had no memory of where the clothes had come from or why she was not in her original outfit. Following that she slept and did not have another worrisome episode. She did complain of her arm hurting for several days and that it was itchy at the injection site. I did not observe any swelling or rashes on her.
the first night I had a sore arm and then for the next 3 days I had chills, sweats, headache, nausea, fatigued and dizziness.
2nd dose of shingrix beyond the 6 month of 1st dose; This non-serious case was reported by a physician via sales rep and described the occurrence of drug dose administration interval too long in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 2nd dose of shingrix beyond the 6 month of 1st dose).  The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 25-SEP-2023 The healthcare professional reported receiving the 2nd dose of Shingrix beyond the 6 month after first dose recommended schedule. The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccinations schedule(Drug dose administration interval too long) plus 7 days.
pt recvd vax 27APR 1130AM; 120PM sz & again 25FEB both for 4 mins; 5MAY sz start phenobarb sz on 20MAY, 24MAY, 24MAY, 27MAY, 28, 29, 30MAY;
15 yo M with chest pain, fever found to have likely myocarditis secondary to likely COVID vaccine (Pfizer) with elevated troponin at OSH of 660 ng/L. Repeat here noted to be 58,513 mg/L but patient otherwise stable, not complaining of chest pain after Toradol and eating more currently.
pt recv vax 17OCT96 & 28OCT96 & pt devel a hematoma in rt shoulder & pain & swelling in rt arm;lab eval revealed a prothrombin time of 37.3 (control 10.0);pt recovered
to ER w/fever of 104;did not get fever until 29JUL98;MD there & pt pediatrician saw pt & recommended APAP alternate w/motrin;blood test not elevated;fever came down by 31JUL98;
Case received both Moderna vaccines 1= 3/24/21 LOT# 017B21A and 2=4/28/21 LOT# 046B21A.  Case had onset of  Covid 19 symptoms on 8/6/21 which included fever, subjective fever, chills, muscle aches, runny nose, sore throat, new olfactory disorders, headache, fatigue, cough and nausea. Case was still symptomatic at time of Disease Investigation on 8/16/21
sore arm near injection site; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "sore arm near injection site"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "headache".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever began overnight with chills, headache, fatigue and upset stomach. Did not resolve until about 12 hours later. Minor headache still present. Sore arm at injection site.
I went into Atrial fibrillation. I had to go to the hospital. They did a cardioversion. They sent me home.
Fever; Chills; Severe headache, 10 to 30 hours post vaccination.
Woke up at midnight with severe nausea abdominal pain and diarrhea; Woke up at midnight with severe nausea abdominal pain and diarrhea; Woke up at midnight with severe nausea abdominal pain and diarrhea; Body aches; headache; arm pain; This is a spontaneous report from a contactable nurse (patient).   A 50-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered in Arm Left on 16Aug2021 16:30 (at the age of 50-years-old) (Batch/Lot Number: FC3183) as single dose for covid-19 immunisation. Medical history included HTN (hypertension). It was unknown if patient had Covid prior vaccination. The patient was not pregnant. The patient was not pregnant at time of vaccination. The patient did not receive other vaccine in four weeks. Concomitant medications included other medications received in two weeks. The patient experienced woke up at midnight with severe nausea abdominal pain and diarrhea on 17Aug2021 00:00. The patient had several bouts of diarrhea and ongoing pain up until current time of 19:00 on 17Aug2021. Body aches, headache and arm pain were also present. All events onset on 17Aug2021 00:00. No treatment received for any events. The patient had not Covid tested post vaccination. The outcome of the events was not recovered.
Pain (7/10) in his arm (presumably at the injection site); Discomfort on the left side of his neck; Headache; Overall feeling sluggish; Chills; This is a spontaneous report from contactable consumer (patient) via Pfizer Sales Representative. A male patient of age 45 (Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Pain (7/10) in his arm (presumably at the injection site), Discomfort on the left side of his neck, Headache, Overall feeling sluggish and Chills (although unsure whether that is due to his house being kept cool). The patient underwent lab tests and procedures which included Pain (pain assessment): 7/10 on an unspecified date. The outcome of events was unknown.  Information about lot/ batch number has been requested.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 24-SEP-2014, the patient was vaccinated with PNEUMOVAX 23, 0.5 ml, intramuscular route (lot # reported as J009027; Exp. Date: 10-AUG-2014). No co-suspect or concomitant therapies were reported. The dose that the patient received was expired. No adverse effects reported. Additional information has been requested.
Initial unsolicited report received from the literature on 31-Jan-2018. Abstract Hydroxychloroquine is an antimalarial drug frequently used to reduce inflammation in autoimmune and inflammatory conditions. In adults, hydroxychloroquine can be used as an alternative agent totreat antihistamine-refractory chronic spontaneous urticaria (CSU).It was unknown whether hydroxychloroquine is safe and effective for treating antihistamine-refractory CSU in children. We present the case of a 9-month-old male infant with 5 months of recurrent, unprovoked hives and swelling who was treated safely and successfully with hydroxychloroquine. The patient was a previously healthy, full-term infant delivered by cesarean section. He was breastfed until 6 weeks of age and switched to a cow's milk-based formula without incident. After resolution of an upper respiratory tract infection at 4 months of age, patient developed recurrent and unprovoked full-body hives. The hives were occasionally associated with angioedema of the hands and feet, would resolve within 24 hours, and were not associated with fevers, residual bruising, lymphadenopathy, or joint swelling. Review ofsystems was negative for constitutional, respiratory, cardiovascular, gastrointestinal, genitourinary, or neurologic symptoms. The hives did not improve with an empiric trial of hypoallergenic formula or elimination of solid foods. The hives were refractory to treatment with diphenhydramine, high-dose cetirizine, ranitidine, and montelukast. The hives resolved with systemic corticosteroids, but quickly recurred when corticosteroids were tapered. Physical examination showed a well-appearing infant with multiple annular urticarial lesions involving the face and body and mild angioedema of the hands and feet. A stroke test revealed marked dermatographism. This case involves an 11-year-old patient (gender was not reported at the time of reaction), who was vaccinated with INFLUENZA VACCINE (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. On an unknown date, patient performed urinalysis, lactate dehydrogenase, uric acid, vitamin b12, lactase dehydrogenase, immunoglobulin A, G, M and E, which results were in normal limits. On an unknown date patient had a medical history of urticarial. Concomitant medications included CETIRIZINE HYDROCHLORIDE (CETRIZINE), RANITIDINE, MONTELUKAST, PREDNISOLONE, and HYDROXYCHLOROQUINE SULFATE (HYDROXYCHLOROQUINE). On an unknown date, following the vaccination patient had hives, recurrence of urticarial, Sporadic outbreak of hives. Patient's other laboratory test included- serum immunoglobulins and at the age of 14 months a opthalmalogic exam was done which results were normal. Corrective treatment was not reported. On an unknown date, patient was recovered from the event at the time of reporting. Documents held by sender: none.
This spontaneous report was received from a 75 years old female consumer with pain, high blood pressure, high cholesterol and no drug reaction/allergies refers to herself. The patient stated that she think she was vaccinated SQ with a dose of ZOSTAVAX (dose and lot# not reported) in 2006. Concomitant medications included PREDNISONE, acetaminophen, LORTAB, PROTONA blood pressure medicine, and cholesterol. The patient stated that in December 2010 she experienced shingles, which was lasting for 3-4 weeks at the time with rash and then it healed. The patient was still suffering from post herpetic neuralgic (PHN). It was reported that the patient sought unspecified medical attention. It was treated with different antivirals. Additional information has been requested.
It started with was a strange headache for a few days. Then, It felt like I had a slight fever. I had a cough, shortness of breath, sore throat, and joint achiness. I still have the headache and joint aches, but everything else is good. My doctor prescribed PAXLOVID to take if I needed it, but I didn't take it. I was fine without any medication.
Patient had inflammation of nerves in the right arm, where Td was administered. Patient complained of arm being sore, red, tender and having limited movement of the arm. Adverse event onset was sometime prior to 02/05/07, when patient contacted the doctor with the complaint. On 02/28/07 patient came for a follow up visit and noted that there was less pain in the arm, although arm movement was still limited. Patient received Td injection to a dog bite. *Continues on next page* Follow up obtained on 03/20/2007: Reporter clarified that during the follow up visit on 02/28/07 patient's arm movement was limited because of pain and that patient had a normal neurological exam and no local inflammation reaction. Patient felt better and has recovered, although it took a month for the pain to go away.
Pfizer-BioNTech COVID-19 Vaccine .  Nausea started around 1:30, vomiting shortly after. Continued to throw up until approx 10am the next morning.   Felt feverish as well.  Had to lay in my car for several hours before my one hour drive home and  threw up in plastic bag while driving. Had to stop and rest and throw up halfway home.  Went to bed when I finally got home and continued to throw up all  night
Information has been received from a pharmacist concerning a 70 year old male patient who on 23-JUL-2010 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck). The pharmacist reported that the patient who was vaccinated at the pharmacy, returned to the pharmacy on 29-JUL-2010, complaining of a three inch round, reddened, non-swollen area near the injection site on the patient's arm that appeared on 27-JUL-2010. No physician was treating the patient for this reaction. At the time of the report the patient was not recovered. Additional information has been requested.
Pt initially noted mild substernal chest pain while running in the afternoon on 3/12/18 which resolved when he stopped running. He awakened the next morning at 0300 on 3/13/18 with a c/o 8/10 burning pain in the center of his chest accompanied by mild shortness of breath. He also some numbness/loss of sensation in his left shoulder down to his elbow which was also present at the time of his chest pain. He was transported to the ED via EMS. While in route his ECG showed diffuse ST elevations and he received 325mg ASA in the ambulance. After arriving in the ED he received IV TORADOL after which his symptoms resolved. Workup in the ED included a bedside ECHO which was followed by an inpatient ECHO both which demonstrated normal LV Systolic function w/o wall motion abnormalities and a small pericardial effusion and elevated troponin c/w myopericarditis. Pt also had elevated troponin levels and ESR and CRP levels. The cardiologists diagnosed him with vaccine related myocarditis. He was admitted for observation and discharged later that same day around 1600 without any further chest pain. He was discharged on Aspirin 325 mg a day, Colchicine 0.6 mg po BID, and PROTONIX 40 mg a day with follow-up with his primary care provider in 2 weeks and a profile for limited physical exertion.
Patient woke up on 11/28/21 with hives over the whole body- this has worsened today.  No other symptoms, the hives are not itchy or bothersome.
About an hour after the vaccines,  felt a tickle in my throat and slight swelling on left side of throat. Took a couple benadryl, but swelling continued to worsen and spread to about 3/4 across my throat at 1.5 hours. Throat felt like it was touching as if I was swallowing food or drink, even when I wasn't eating/drinking. Sucked on ice chips to sooth and slow swelling. Also started to get numb on the left side of lips and face (like after a local at the dentist for fillings/crowns) at 1.75 hours. No issues with breathing occurred, so went into urgent care (arrived at 2 hour mark). Urgent care decided it was an acute reaction, not severe and gave me a steroid injection, at 2.5 hour mark, and said to continue Benadryl at home. Head to the ER if symptoms worsen or any trouble breathing. Item 21 unavailable to completely report at this time.
Employee c/o Redness,swelling and pain at injection site. It has been 4 days since injection of Tdap. Advised her to take 25 mg Benydrl PO for swelling and Tylenol for discomfort. Instructed her to come to Employee Health to see the MD if symptoms presist.
Fever and chills with fever up to 103? degrees.  Fever lasted for a little over 15 hours. Sore throat the next morning only and negative rapid test x2.
High fever treated with Motrin, which would reduce the fever for 2 hours.  Fever spiked at 104 F each night as Motrin wore off.  IV antibiotics were administered as a precaution.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. On 16-NOV-2015, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose and route of administration were not specified); lot # L035686 and expiration date on 16-FEB-2017 that "might" have been improperly stored (it was unknown if the vaccines underwent a temperature excursion). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
I took a J&J vaccine on March 17 and then had big side effects: Chills, fever, rashes, fatigue and right leg muscle beating.  After two weeks (April 8) I had severe left leg pain like needles punching my body.I rushed to hospital emergency Department for the medical examination and treatment. Doctor diagnosed me with shingles.  So far (Aug 3) I haven?t recovered and feel Chills, rashes and acupuncture pain.
6-3-16 Pt. received PREVNAR 13 vaccine during an annual physical appt. -> Pt. stated arm (left deltoid area) was sore, so she took TYLENOL. 6-4-16 Pt. noted red/swollen arm that gradually increased to cover upper arm from injection site to elbow. 6-9-16 Pt. just reporting the reaction in clinic, given BENADRYL 25 mg PO and prescribed Prednisone.